Breaking News

Dermatology Drug Market To Grow 8% a Year to 2008

November 22, 2005

The Dermatology Drug market will grow 8% a year to 2008, led by demand for psoriasis treatments, according to the “Dermatology pipeline analysis: a market with room to grow” report by Decision Resources (DR), Waltham, MA. This is largely due to the Food and Drug Administration’s approval of Enbrel, an Amgen-based treatment for adults with moderate-to-severe chronic plaque psoriasis. Medications for atopic dermatitis will also increase, but uticario medications will decline.
  • It’s Magic!

    It’s Magic!

    Melissa Meisel, Associate Editor||March 20, 2017
    Argan oil-infused ‘Moroccan’ lip care brand jumps from WholeFoods into CVS.

  • On the Cutler Edge

    On the Cutler Edge

    Melissa Meisel, Associate Editor||March 13, 2017
    Top brand source at Redken forecasts up-to-the-minute hair trends.

  • Take The Hint

    Take The Hint

    Christine Esposito, Associate Editor||March 13, 2017
    Water brand forays into sun protection by capitalizing on scent and experience.

  • Supply-Side Innovations

    Supply-Side Innovations

    Tom Branna, Editorial Director||March 1, 2017
    Raw material suppliers roll up their sleeves and roll out their new products for the global cleaning industry.

  • New Faces in Familiar Places

    New Faces in Familiar Places

    Tom Branna, Editorial Director||March 1, 2017
    The American Cleaning Institute officially welcomed its new president.

  • Special Delivery

    Special Delivery

    Tom Branna, Editorial Director||March 1, 2017
    UV protection is important, but what good is that sunscreen if consumers won’t apply it?